Who
Anupam Dalal
Director
Company insider
Files Form 4 as: Director, Whitehawk Therapeutics; Director, Akebia Therapeutics.
In numbers
- Trades disclosed
- 23
- Buys
- 2
- Sells
- 0
- Bought
- $40.0M
- Sold
- $0
- Companies
- 2
- Companies where not an officer
- 2
- First trade
- 10 Jun 2015
- Last trade
- 12 Jun 2026
- Last filed
- 30 Jul 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 12 Jun 2026filed 30 Jul 2026 | WHWK Whitehawk Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —38,040 at $0.00 | filing |
| 12 Jun 2026filed 30 Jul 2026 | WHWK Whitehawk Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —38,040 at $0.00 | filing |
| 14 May 2026filed 30 Jul 2026 | WHWK Whitehawk TherapeuticsBiotechnology | SEC FORM 4 Code A | $5.0M1,275,510 at $3.92 | filing |
| 14 May 2026filed 30 Jul 2026 | WHWK Whitehawk TherapeuticsBiotechnology | SEC FORM 4 Code A | $5.0M1,275,510 at $3.92 | filing |
| 12 Jun 2025filed 16 Jun 2025 | WHWK Whitehawk Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —40,006 at $0.00 | filing |
| 4 Mar 2025filed 5 Mar 2025 | WHWK Whitehawk TherapeuticsBiotechnology | SEC FORM 4 Code A | $3.7M1,561,000 at $2.40 | filing |
| 12 Jun 2024filed 14 Jun 2024 | WHWK Whitehawk Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —45,832 at $0.00 | filing |
| 15 Jun 2023filed 20 Jun 2023 | WHWK Whitehawk Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —28,255 at $0.00 | filing |
| 26 Sep 2022filed 27 Sep 2022 | WHWK Whitehawk TherapeuticsBiotechnology | SEC FORM 4 Code A | $4.0M320,000 at $12.50 | filing |
| 15 Jun 2022filed 17 Jun 2022 | WHWK Whitehawk Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —18,573 at $0.00 | filing |
| 27 Aug 2021filed 30 Aug 2021 | WHWK Whitehawk Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —17,549 at $0.00 | filing |
| 26 Aug 2021filed 31 Aug 2021 | WHWK Whitehawk TherapeuticsBiotechnology | SEC FORM 4 Bought | $20.0M1,529,402 at $13.08 | filing |
| 26 Aug 2021filed 30 Aug 2021 | WHWK Whitehawk TherapeuticsBiotechnology | SEC FORM 4 Bought | $20.0M1,529,402 at $13.08 | filing |
| 30 Jun 2021filed 2 Jul 2021 | WHWK Whitehawk TherapeuticsBiotechnology | SEC FORM 4 Code A | $11K7,400 at $1.52 | filing |
| 31 Mar 2021filed 2 Apr 2021 | WHWK Whitehawk TherapeuticsBiotechnology | SEC FORM 4 Code A | $11K7,290 at $1.54 | filing |
| 1 Feb 2021filed 3 Feb 2021 | WHWK Whitehawk Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —17,857 at $0.00 | filing |
| 24 Jun 2020filed 26 Jun 2020 | WHWK Whitehawk Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —52,144 at $0.00 | filing |
| 18 Jun 2019filed 19 Jun 2019 | WHWK Whitehawk Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —21,400 at $0.00 | filing |
| 20 Jun 2018filed 22 Jun 2018 | WHWK Whitehawk Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —21,400 at $0.00 | filing |
| 22 Dec 2017filed 14 Feb 2018 | WHWK Whitehawk TherapeuticsBiotechnology | SEC FORM 4 Code J | —7,882 at $0.00 | filing |
News
Whitehawk Therapeutics (NASDAQ:WHWK) versus BeyondSpring (NASDAQ:BYSI) Financial SurveyWHWK · themarketsdaily.com · 23 Oct 2026Financial Review: Whitehawk Therapeutics (NASDAQ:WHWK) and BeyondSpring (NASDAQ:BYSI)WHWK · dailypolitical.com · 17 Oct 2026
0 headlines in the last 90 days name Anupam Dalal; 2 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.